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Background: Whether patients with severe left atrial (LA) enlargement should be considered for catheter ablation of atrial fibrillation (AF) remains 
unclear. In addition, LA remodeling after ablation in this subset of patients has not been studied.
Methods: Fifty patients with LA diameter (LAD) ≥50mm, undergoing catheter ablation for drug-refractory AF were included in this study. 
Transthoracic echocardiographic measurements were obtained at baseline and 12-month post procedure with the investigators being blinded to 
the study outcomes. All patients underwent pulmonary vein antrum, posterior wall isolation and extra PV trigger(s) ablation. Long-term outcome was 
monitored by event recordings, 7-day Holters and office visits.
Results: The mean age was 65±10 years, 78% male, persistent AF 22 (44%), longstanding AF 28 (56%), LAD diameter 56.9±7.8 mm, LVEF 53±14 
and median AF duration 72 (49-96) months. At 12 month follow-up, 27 pts (54%) remained arrhythmia-free off-AAD. Significant reduction in LAD at 
follow-up (≥10% reduction) was observed in 52% (26/50) of the total population and among 63% (17/27) of recurrence-free patients. Magnitude of 
LA reduction was identically distributed among the persistent and LS persistent AF cohorts (16±12% vs. 14±16% respectively, p=0.15). A significant 
20% improvement in LVEF (from 53±14 to 58±9, p=0.03) was found in the overall population. Improvement was noted ín recurrence-free patients. 
After adjusting for baseline risk factors in multivariable model, long-term success was identified as a strong predictor of reduction in LAD (beta=-
11.1, p=0.013). Pre-existing LA scarring was associated with increased LAD (beta=2.7, p=0.023). No peri-procedural or long-term complications 
were reported.
Conclusions: This study shows that catheter AF ablation is effective in nonparoxysmal AF pts with severe LA enlargement and is associated with 
reverse remodeling of the LA and improvement of LVEF.
